Rapid, combined and personalized non-invasive stimulation of the precuneus improves associative memory, enhances local gamma expression, and strengthens precuneus–hippocampal connectivity.
Ovid plans to advance OV329 into a Phase 2a study in drug-resistant focal onset seizures (FOS) and completing a final enabling study to support regulatory filings for its first oral KCC2 direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback